4.4 Article

Pityriasis rosea associated with imatinib (STI571,Gleevec)

Journal

DERMATOLOGY
Volume 205, Issue 2, Pages 172-173

Publisher

KARGER
DOI: 10.1159/000063900

Keywords

adverse drug reaction; STI571; leukemia; Gleevec

Categories

Ask authors/readers for more resources

A tyrosine kinase inhibitor (STI571, Gleevec) has recently been applied in the treatment of chronic myeloid leukemia. We present the first reported case of pityriasis rosea occurring as a reaction to Gleevec in a woman with blast crisis of this disorder. It is suggested that although coincidental, this exanthem may be due to this agent. Copyright (C) 2002 S. Karger AG, Basel.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available